Impact of proton pump inhibitors on clinical outcomes in patients after acute myocardial infarction: a propensity score analysis from China Acute Myocardial Infarction (CAMI) registry

BACKGROUND: Proton pump inhibitors (PPIs) are recommended by the latest guidelines to reduce the risk of bleeding in acute myocardial infarction (AMI) patients treated with dual antiplatelet therapy (DAPT). However, previous pharmacodynamic and clinical studies have reported controversial results on...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Geriatr Cardiol
Huvudupphovsmän: SHI, Wen-Ce, GAO, Si-De, YANG, Jin-Gang, FAN, Xiao-Xue, NI, Lin, SU, Shu-Hong, YU, Mei, YANG, Hong-Mei, YU, Meng-Yue, YANG, Yue-Jin, on behalf of China Acute Myocardial In-farction (CAMI) Registry study group
Materialtyp: Artigo
Språk:Inglês
Publicerad: Science Press 2020
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7729183/
https://ncbi.nlm.nih.gov/pubmed/33343644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11909/j.issn.1671-5411.2020.11.008
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk